Your Feed

Filter by
See content from
Back to the latest
Avatar
SetyBlue
Multiple Myeloma Discussion • December 12, 2023
Experiencing Tingling and Weakness From Bactrim?
AI-generated title
I have been put on Bactrim (sulfamemethoxazole and trimethoprim) anti bacterial pills after ASCT. I am taking this drug three times a week, on Mondays, Wednesdays and Fridays. I am supposed to be on it for at least two months but I think I am getting weird side effects from it. I’ve been on it for a month now, and I have noticed that by Friday there’s tingling in my hands and feet, and I think I am getting some muscle weakness and slight dizziness as well. After being off it for Saturday and Sunday, some of the side effects are lessened, but then get worse by Friday. Has anyone experienced this with this drug?
Avatar
grayDolphin
Multiple Myeloma Discussion • December 12, 2023
Interpreting Pre-SCT Biopsy Results?
AI-generated title
Can someone interpret these results of husbands pre-stem cell bone marrow biopsy that was completed post RVD therapy (SCT is next week) Thanks! FINAL DIAGNOSIS A-D. Bone marrow, right iliac crest, aspirate with clot preparation and biopsy with touch imprints, and peripheral blood smear: 1. Monotypic lambda light chain restricted, hyperdiploid, plasma cells, 3% by morphologic differential. 2. Normocellular bone marrow for age (25%) with unremarkable background trilineage hematopoiesis.
Thumbnail for Addressing Racial and Ethnic Disparities in AML Clinical Trials | Andrew Hantel, MD | ASH 2023
Playlist: ASH 2023

Addressing Racial and Ethnic Disparities in AML Clinical Trials | Andrew Hantel, MD | ASH 2023

Video details & playlist
Thumbnail for Study on Minimizing Exclusion for AML Patients in Clinical Trials | Andrew Hantel, MD | ASH 2023
Playlist: ASH 2023

Study on Minimizing Exclusion for AML Patients in Clinical Trials | Andrew Hantel, MD | ASH 2023

Video details & playlist
Thumbnail for Loncastuximab for High-Risk Relapsed/Refractory FL | Juan Pablo Alderuccio, MD | ASH 2023
Playlist: ASH 2023

Loncastuximab for High-Risk Relapsed/Refractory FL | Juan Pablo Alderuccio, MD | ASH 2023

Video details & playlist
Thumbnail for Results from Venetoclax Added to CLAD Combo for Older Patients With AML | Tapan Kadia, MD | ASH 2023
Playlist: ASH 2023

Results from Venetoclax Added to CLAD Combo for Older Patients With AML | Tapan Kadia, MD | ASH 2023

Video details & playlist
Thumbnail for Costs & Financial Hardship Among BMT CTN 1102 Patients MDS | Christopher Su, MD | ASH 2023
Playlist: ASH 2023

Costs & Financial Hardship Among BMT CTN 1102 Patients MDS | Christopher Su, MD | ASH 2023

Video details & playlist
Thumbnail for Costs of Venetoclax-Obinutuzumab vs. BTKi in CLL | Scott Huntington, MD, MPH, MSc | ASH 2023
Playlist: ASH 2023

Costs of Venetoclax-Obinutuzumab vs. BTKi in CLL | Scott Huntington, MD, MPH, MSc | ASH 2023

Video details & playlist
Thumbnail for Moving to a Fully Oral Drug Combination for Older/Frail AML Patients | Tapan Kadia, MD | ASH 2023
Playlist: ASH 2023

Moving to a Fully Oral Drug Combination for Older/Frail AML Patients | Tapan Kadia, MD | ASH 2023

Video details & playlist
Thumbnail for Exploring Drug Options for MDS Patients with XPO1 Inhibitors | Justin Taylor, MD & Sana Chaudhry, BS | ASH 2023
Playlist: ASH 2023

Exploring Drug Options for MDS Patients with XPO1 Inhibitors | Justin Taylor, MD & Sana Chaudhry, BS | ASH 2023

Video details & playlist
Thumbnail for Extending AML Remissions with Hypomethylating Agents and Venetoclax | Tapan Kadia, MD | ASH 2023
Playlist: ASH 2023

Extending AML Remissions with Hypomethylating Agents and Venetoclax | Tapan Kadia, MD | ASH 2023

Video details & playlist
Thumbnail for Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023
Playlist: ASH 2023

Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023

Video details & playlist
Thumbnail for Real World Teclistamab Results for Relapsed Refractory Myeloma Patients | Meera Mohan, MD | ASH 2023
Playlist: ASH 2023

Real World Teclistamab Results for Relapsed Refractory Myeloma Patients | Meera Mohan, MD | ASH 2023

Video details & playlist
Thumbnail for Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023
Playlist: ASH 2023

Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023

Video details & playlist
Thumbnail for Updates to Management of CAR-T and Teclistamab for Myeloma Patients | Radhika Bansal, MD | ASH 2023
Playlist: ASH 2023

Updates to Management of CAR-T and Teclistamab for Myeloma Patients | Radhika Bansal, MD | ASH 2023

Video details & playlist